MLA Diagnostics receives a place in the MSD LAB1891 programme

LAB1891 and UtrechtInc will partner up to support 3 early stage startups selected by MSD to help innovation in their focus area. 

The programme provided coaching, workshops and access to a global network of expertise. MLA Diagnostics gained valuable clinical insights into pharma drivers and interests in biomarker applications in general, companion diagnostics, predictive biomarkers and personalised medicine.